MIDACORE
LIVE

Serial Number

79240518

Owner

Midatech Limited

Attorney

Manuel Valcarcel, Esq.

Filing Date

Feb 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MIDACORE Trademark

Serial Number: 79240518 • Registration: 5963820

MIDACORE is a trademark filed by Midatech Limited on February 20, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Midatech Limited (9 trademarks)

Oddfellows House,

Entity Type: 99

Trademark Details

Filing Date

February 20, 2018

Registration Date

January 21, 2020

Published for Opposition

November 5, 2019

Goods & Services

Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others

Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles

Nano-particles for use as active ingredients in the manufacture of cosmetics; nano-particles for use as active ingredients in the manufacture of pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles for use as carriers for cosmetics; nano-particles for use as carriers for pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders

Scientific research services in the field of nano-particle technology; pharmaceutical and drug development and discovery services, namely, pharmaceutical research and development; advisory services in the field of design, development and scientific research of nano-particles, pharmaceuticals and nano-medicine; product testing of nano-particles, pharmaceuticals and nano-medicine; nano-particle product quality testing, product quality evaluation and scientific research laboratory services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 21, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 2, 2020 FICS
FINAL DISPOSITION PROCESSED
May 2, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 21, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 1, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 16, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 16, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 1, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 30, 2019 GNFN
FINAL REFUSAL E-MAILED
Apr 30, 2019 GNFR
FINAL REFUSAL WRITTEN
Apr 30, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 15, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 15, 2019 REAP
REFUSAL PROCESSED BY IB
Oct 13, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 27, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 24, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 21, 2018 MAFR
ASSIGNED TO EXAMINER
Sep 17, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 13, 2018 REPR